文献速递结核与非结核分枝杆菌

在五个中低收入国家儿童中序贯与平行检测对结核病微生物学确诊的研究:RaPaed-TB 研究的二次分析

Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: a secondary analysis of the RaPaed-TB study.
PubMed 文献 · Lancet Infect Dis · 2024-09-20

该二次分析基于 RaPaed-TB 多中心诊断准确性研究,纳入五个中低收入国家 965 名有结核症状的 15 岁以下儿童,评估平行采样与同步检测对微生物学确诊的检出率。结果显示 239 名(25%)确诊结核,其中 82% 经 Xpert MTB/RIF Ultra 检出,平行采样与同步检测可提高儿童结核微生物学确诊率。

要点

  • 965 名儿童中 239 名(25%)为确诊结核,282 名(29%)为未确诊结核,444 名(46%)为不太可能结核。
  • 239 名确诊儿童中 196 名(82%)经 Ultra 检出,110 名(46%)经 Ultra 和培养共同确认。
  • 5 岁以下且检出结核的 102 名儿童中 80 名(78%)痰标本阳性,其中 64 名(80%)仅痰阳性。

核心结论

  • 通过平行采样和同步检测流程可在儿童中获得较高的结核病微生物学确诊率。
  • 应用于 5 岁以下儿童、HIV 感染儿童或严重急性营养不良儿童等群体时,应考虑样本类型和序贯检测方法的选择。

研究设计与样本

  • 本研究为 RaPaed-TB 多中心诊断准确性研究的二次分析,评估儿童结核病新型诊断 assays 和检测方法。
  • 研究在马拉维、莫桑比克、南非、坦桑尼亚和印度的五个卫生中心开展,招募时间为 2019 年 1 月 21 日至 2021 年 6 月 30 日。
  • 纳入 15 岁以下有肺结核或肺外结核体征或症状的儿童,排除体重低于 2 kg、入组时已接受三剂或以上抗结核药物、被当地研究者判定为危重状态或无至少一项有效微生物学结果的儿童。
  • 共筛查 5313 名儿童,纳入 975 名,其中 965 名(99%)有至少一项有效微生物学结果。
  • 通过自发痰、诱导痰、胃吸出物和鼻咽吸出物采集结核参考标本,检测方法包括 Xpert MTB/RIF Ultra(简称 Ultra)、液体培养和 Löwenstein-Jensen 固体培养,阳性培养后行确认试验。

主要发现

  • 965 名儿童中,444 名(46%)为不太可能结核,282 名(29%)为未确诊结核,239 名(25%)为确诊结核。
  • 中位年龄为 5.0 岁(IQR 1.8-9.0);467 名(48%)为女性,498 名(52%)为男性;155 名(16%)有 HIV 感染,110 名(11%)有严重急性营养不良。
  • 239 名有微生物学检出的儿童中,196 名(82%)经 Ultra 检测阳性;110 名(46%)经 Ultra 和培养共同确认,86 名(36%)仅经 Ultra 确认,43 名(18%)仅经培养确认。
  • 半定量结果中最常见为「Trace」,234 名中 93 名(40%)为此结果;965 名儿童中 481 名(50%)仅采集一种标本类型,其中 99 名(21%)检出结核分枝杆菌;484 名(50%)采集多种标本,其中 141 名(29%)至少一种标本类型阳性。
  • 5 岁以下且检出结核分枝杆菌的 102 名儿童中,80 名(78%)痰标本阳性;80 名痰阳性儿童中 64 名(80%)仅痰阳性,其中 61 名(95%)为诱导痰阳性,2 名(3%)为自发痰阳性,1 名(2%)两者均阳性。

临床怎么用

  • 作者认为,通过平行采样和同步检测流程可在儿童中获得较高的结核病微生物学确诊率。
  • 作者建议,应用于 5 岁以下儿童、HIV 感染儿童或严重急性营养不良儿童等群体时,应考虑样本类型和序贯检测方法的选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite causing high mortality worldwide, paediatric tuberculosis is often undiagnosed. We aimed to investigate optimal testing strategies for microbiological confirmation of tuberculosis in children younger than 15 years, including the yield in high-risk subgroups (eg, children younger than 5 years, with HIV, or with severe acute malnutrition [SAM]). METHODS: For this secondary analysis, we used data from RaPaed-TB, a multicentre diagnostic accuracy study evaluating novel diagnostic assays and testing approaches for tuberculosis in children recruited from five health-care centres in Malawi, Mozambique, South Africa, Tanzania, and India conducted between Jan 21, 2019, and June 30, 2021. Children were included if they were younger than 15 years and had signs or symptoms of pulmonary or extrapulmonary tuberculosis; they were excluded if they weighed less than 2 kg, had received three or more doses of anti-tuberculosis medication at time of enrolment, were in a condition deemed critical by the local investigator, or if they did not have at least one valid microbiological result. We collected tuberculosis-reference specimens via spontaneous sputum, induced sputum, gastric aspirate, and nasopharyngeal aspirates. Microbiological tests were Xpert MTB/RIF Ultra (hereafter referred to as Ultra), liquid culture, and Löwenstein-Jensen solid culture, which were followed by confirmatory testing for positive cultures. The main outcome of this secondary analysis was categorising children as having confirmed tuberculosis if culture or Ultra positive on any sample, unconfirmed tuberculosis if clinically diagnosed, and unlikely tuberculosis if neither of these applied. FINDINGS: Of 5313 children screened, 975 were enrolled, of whom 965 (99%) had at least one valid microbiological result. 444 (46%) of 965 had unlikely tuberculosis, 282 (29%) had unconfirmed tuberculosis, and 239 (25%) had confirmed tuberculosis. Median age was 5·0 years (IQR 1·8-9·0); 467 (48%) of 965 children were female and 498 (52%) were male. 155 (16%) of 965 children had HIV and 110 (11%) children had SAM. 196 (82%) of 239 children with microbiological detection tested positive on Ultra. 110 (46%) of 239 were confirmed by both Ultra and culture, 86 (36%) by Ultra alone, and 43 (18%) by culture alone. 'Trace' was the most common semiquantitative result (93 [40%] of 234). 481 (50%) of 965 children had only one specimen type collected, 99 (21%) of whom had M tuberculosis detected. 484 (50%) of 965 children had multiple specimens collected, 141 (29%) of whom were positive on at least one specimen type. Of the 102 children younger than 5 years with M tuberculosis detected, 80 (78%) tested positive on sputum. 64 (80%) of 80 children who tested positive on sputum were positive on sputum alone; 61 (95%) of 64 were positive on induced sputum, two (3%) of 64 were positive on spontaneous sputum, and one (2%) was positive on both. INTERPRETATION: High rates of microbiological confirmation of tuberculosis in children can be achieved via parallel sampling and concurrent testing procedures. Sample types and choice of test to be used sequentially should be considered when applying to groups such as children younger than 5 years, living with HIV, or with SAM. FUNDING: European and Developing Countries Clinical Trials Partnership programme, supported by the EU, the UK Medical Research Council, Swedish International Development Cooperation Agency, Bundesministerium für Bildung und Forschung, the German Center for Infection Research, and Beckman Coulter.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Olbrich L, Franckling-Smith Z, Larsson L, et al. Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: a secondary analysis of the RaPaed-TB study. Lancet Infect Dis. 2024. PMID: 39312914. doi:10.1016/S1473-3099(24)00494-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。